Cargando…

Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort

OBJECTIVES: The International Consensus Diagnostic Criteria (ICDC) designed to diagnosis autoimmune pancreatitis (AIP) has been proposed recently. The diagnostic performance of ICDC has not been previously evaluated in diffuse-type and focal-type AIP, respectively, in comparison with the revised HIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ming-Chu, Liang, Po-Chin, Jan, I-Shiow, Yang, Ching-Yao, Tien, Yu-Wen, Wei, Shu-Chen, Wong, Jau-Min, Chang, Yu-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139642/
https://www.ncbi.nlm.nih.gov/pubmed/25138812
http://dx.doi.org/10.1136/bmjopen-2014-005900
_version_ 1782331386109100032
author Chang, Ming-Chu
Liang, Po-Chin
Jan, I-Shiow
Yang, Ching-Yao
Tien, Yu-Wen
Wei, Shu-Chen
Wong, Jau-Min
Chang, Yu-Ting
author_facet Chang, Ming-Chu
Liang, Po-Chin
Jan, I-Shiow
Yang, Ching-Yao
Tien, Yu-Wen
Wei, Shu-Chen
Wong, Jau-Min
Chang, Yu-Ting
author_sort Chang, Ming-Chu
collection PubMed
description OBJECTIVES: The International Consensus Diagnostic Criteria (ICDC) designed to diagnosis autoimmune pancreatitis (AIP) has been proposed recently. The diagnostic performance of ICDC has not been previously evaluated in diffuse-type and focal-type AIP, respectively, in comparison with the revised HISORt and Asian criteria in Taiwan. DESIGN: Prospective, consecutive patient cohort. SETTING: Largest tertiary referred centre hospital managing pancreatic disease in Taiwan. PARTICIPANTS: 188 patients with AIP and 130 with tissue proofed pancreatic adenocarcinoma were consecutively recruited. INTERVENTIONS: The ICDC, as well as revised HISORt and Asian criteria, was applied for each participant. Each diagnostic criterion of ICDC was validated with special reference to levels 1 and 2 in diffuse-type and focal-type AIP. OUTCOMES: Sensitivity, specificity and accuracy. Each diagnostic criterion of ICDC was validated with special reference to levels 1 and 2 in AIP and focal-type AIP. RESULTS: The sensitivity, specificity and accuracy of ICDC for all AIP were the best: 89.4%, 100% and 93.7%, respectively, in these three criteria. The sensitivity, specificity and accuracy of ICDC for focal-type AIP (84.9%, 100% and 93.8%) were also the best among these three criteria. The area under the curve of receiver-operator characteristic of ICDC was 0.95 (95% CI 0.92 to 0.97) in all AIP and 0.93 (95% CI 0.88 to 0.97) in focal-type AIP. CONCLUSIONS: The sensitivity, specificity and accuracy of ICDC are higher than the revised HISORt and Asian criteria. The sensitivity, specificity and accuracy of each criterion are higher in diffuse-type AIP compared with focal-type AIP. Under the same specificity, the sensitivity and accuracy of ICDC are higher than other diagnostic criteria in focal-type AIP. ICDC has better diagnostic performance compared with previously proposed diagnostic criteria in diffuse-type and focal-type AIP.
format Online
Article
Text
id pubmed-4139642
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41396422014-08-25 Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort Chang, Ming-Chu Liang, Po-Chin Jan, I-Shiow Yang, Ching-Yao Tien, Yu-Wen Wei, Shu-Chen Wong, Jau-Min Chang, Yu-Ting BMJ Open Gastroenterology and Hepatology OBJECTIVES: The International Consensus Diagnostic Criteria (ICDC) designed to diagnosis autoimmune pancreatitis (AIP) has been proposed recently. The diagnostic performance of ICDC has not been previously evaluated in diffuse-type and focal-type AIP, respectively, in comparison with the revised HISORt and Asian criteria in Taiwan. DESIGN: Prospective, consecutive patient cohort. SETTING: Largest tertiary referred centre hospital managing pancreatic disease in Taiwan. PARTICIPANTS: 188 patients with AIP and 130 with tissue proofed pancreatic adenocarcinoma were consecutively recruited. INTERVENTIONS: The ICDC, as well as revised HISORt and Asian criteria, was applied for each participant. Each diagnostic criterion of ICDC was validated with special reference to levels 1 and 2 in diffuse-type and focal-type AIP. OUTCOMES: Sensitivity, specificity and accuracy. Each diagnostic criterion of ICDC was validated with special reference to levels 1 and 2 in AIP and focal-type AIP. RESULTS: The sensitivity, specificity and accuracy of ICDC for all AIP were the best: 89.4%, 100% and 93.7%, respectively, in these three criteria. The sensitivity, specificity and accuracy of ICDC for focal-type AIP (84.9%, 100% and 93.8%) were also the best among these three criteria. The area under the curve of receiver-operator characteristic of ICDC was 0.95 (95% CI 0.92 to 0.97) in all AIP and 0.93 (95% CI 0.88 to 0.97) in focal-type AIP. CONCLUSIONS: The sensitivity, specificity and accuracy of ICDC are higher than the revised HISORt and Asian criteria. The sensitivity, specificity and accuracy of each criterion are higher in diffuse-type AIP compared with focal-type AIP. Under the same specificity, the sensitivity and accuracy of ICDC are higher than other diagnostic criteria in focal-type AIP. ICDC has better diagnostic performance compared with previously proposed diagnostic criteria in diffuse-type and focal-type AIP. BMJ Publishing Group 2014-08-16 /pmc/articles/PMC4139642/ /pubmed/25138812 http://dx.doi.org/10.1136/bmjopen-2014-005900 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Gastroenterology and Hepatology
Chang, Ming-Chu
Liang, Po-Chin
Jan, I-Shiow
Yang, Ching-Yao
Tien, Yu-Wen
Wei, Shu-Chen
Wong, Jau-Min
Chang, Yu-Ting
Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title_full Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title_fullStr Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title_full_unstemmed Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title_short Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
title_sort comparison and validation of international consensus diagnostic criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a taiwanese cohort
topic Gastroenterology and Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139642/
https://www.ncbi.nlm.nih.gov/pubmed/25138812
http://dx.doi.org/10.1136/bmjopen-2014-005900
work_keys_str_mv AT changmingchu comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT liangpochin comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT janishiow comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT yangchingyao comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT tienyuwen comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT weishuchen comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT wongjaumin comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort
AT changyuting comparisonandvalidationofinternationalconsensusdiagnosticcriteriafordiagnosisofautoimmunepancreatitisfrompancreaticcancerinataiwanesecohort